GenEdit Closes $8.5 million Series Seed Financing

BERKELEY, Calif., Dec. 11, 2018 -- (Healthcare Sales & Marketing Network) -- GenEdit, Inc., a developer of novel polymer nanoparticle technology platform for non-viral-based delivery of gene therapeutics, today announced the completion of a $8.5 million S... Regenerative Medicine, Venture Capital GenEdit, gene therapeutics, CRISPR
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news